2012
DOI: 10.1007/978-1-4614-2098-9_13
|View full text |Cite
|
Sign up to set email alerts
|

Multipotent Mesenchymal Stromal Cells: Clinical Applications and Cancer Modeling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(20 citation statements)
references
References 131 publications
0
20
0
Order By: Relevance
“…Nowadays, there are several surgical techniques that include the direct repair (Matsuyama et al, 2000), neurotization (Karol, 2003) and nerve grafting (Mafi et al, 2012). Most of these reconstruction strategies, however, have met with only modest success (Matsuyama et al, 2000;Rodriguez et al, 2012). Therefore, recent advances in nanotechnology and tissue engineering have attracted much interest to possibly provide feasible solutions for a broad range of applications in regenerative medicine and to help designing more effective strategies for anatomical and functional repair (Subramanian et al, 2009).…”
Section: Potential Of Msc In the Treatment Of Peripheral Nerve Injurymentioning
confidence: 99%
“…Nowadays, there are several surgical techniques that include the direct repair (Matsuyama et al, 2000), neurotization (Karol, 2003) and nerve grafting (Mafi et al, 2012). Most of these reconstruction strategies, however, have met with only modest success (Matsuyama et al, 2000;Rodriguez et al, 2012). Therefore, recent advances in nanotechnology and tissue engineering have attracted much interest to possibly provide feasible solutions for a broad range of applications in regenerative medicine and to help designing more effective strategies for anatomical and functional repair (Subramanian et al, 2009).…”
Section: Potential Of Msc In the Treatment Of Peripheral Nerve Injurymentioning
confidence: 99%
“…Simultaneously, these CAF-like MSC also promote tumor cell growth both, in vitro and in an in vivo co-implantation model [135]. Likewise, MSC transformed with specific mutations play an important role in sarcoma genesis and in the control of sarcoma tumor growth [136,137]. Furthermore, MSC which have been isolated from primary breast cancer tissues significantly promote tumor growth and size following co-transplantation with breast cancer cells.…”
Section: Interaction Of Msc With Tumor Cells and A Tumorigenic Microementioning
confidence: 99%
“…Thus, in vivo models capable of integrating both the nature of the target cell for transformation, the underlying oncogenic lesions, and the influence of the microenvironment will constitute a valuable model to study tumor biology and to assess potential novel therapeutic approaches [48]. Solid evidence indicates that MSCs and/or MSC-derived progenitors represent the TIC for human sarcomas [1][2][3][4]. Likewise, normal, nonmalignant MSC-like cells have been isolated at high frequencies from primary OS samples, suggesting that normal MSCs could be recruited to the microenvironment of OS and play a role in the development of the disease [49].…”
Section: Discussionmentioning
confidence: 99%
“…Over the last years, mesenchymal stromal/ stem cells (MSCs) and/or MSC-derived lineagespecific progenitors have been proposed as the cell of origin for certain soft tissue sarcomas (STS) and primary bone sarcomas [1][2][3][4]. Within bone sarcomas, osteosarcoma (OS) constitutes the most frequent one comprising approximately 20% of new diagnosis [5,6].…”
Section: Introductionmentioning
confidence: 99%